Sectoral Asset Management’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-600,242
Closed -$51M 112
2020
Q3
$51M Buy
600,242
+68,447
+13% +$3.46M 4.39% 1
2020
Q2
$18.8M Sell
531,795
-230,328
-30% -$6.73M 1.73% 17
2020
Q1
$10.3M Buy
762,123
+70,000
+10% +$1.18M 1.97% 16
2019
Q4
$14.6M Sell
692,123
-217,699
-24% -$3.84M 2.19% 16
2019
Q3
$12.1M Buy
909,822
+490,922
+117% +$7.22M 2.08% 17
2019
Q2
$5.81M Buy
+418,900
New +$6.3M 0.69% 52
2019
Q1
Sell
-1,301,305
Closed -$18.6M 115
2018
Q4
$18.6M Buy
1,301,305
+529,998
+69% +$10.5M 2.52% 10
2018
Q3
$16.1M Buy
771,307
+75,572
+11% +$1.79M 1.71% 20
2018
Q2
$16.5M Buy
+695,735
New +$14M 1.84% 22

Sectoral Asset Management's IMMU Position: Q4 2020 in Review

Sectoral Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 600,242 shares — an estimated $51M sold.

Sectoral Asset Management first reported a position in IMMU in Q2 2018 and held it in 9 quarters. The position peaked at $51M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Sectoral Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Sectoral Asset Management sold 600,242 Immunomedics Inc shares in Q4 2020, an estimated $51M.
  • Sectoral Asset Management first reported a position in Immunomedics Inc in Q2 2018 and held it in 9 quarters.
  • Sectoral Asset Management's Immunomedics Inc position peaked at $51M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Sectoral Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.